Close

Baird Reiterates a 'Neutral' on Onyx Pharmaceuticals (ONXX); Lightning Strikes: Regorafenib CRC Success Adds Meaningfully to Valuation Oct 26, 2011 12:31PM
Baird Maintains an 'Outperform' on Onyx Pharmaceuticals (ONXX); Hitting Pay Dirt on Bayer Settlement and Nexavar Restructuring Oct 12, 2011 01:19PM
Baird Reiterates a 'Neutral' on Onyx Pharmaceuticals (ONXX); Carfil Pathway Remains High-Risk, Regardless of Brentuximab Panel Outcome Jul 12, 2011 02:54PM
Baird Still On the Sidelines After Onyx Pharmaceuticals' (ONXX) Positive Carfilzomib Update Jul 26, 2010 10:42AM
Baird Downgrades Onyx Pharmaceuticals (ONXX) to Neutral; Nexavar Issues More Than Just Seasonality May 5, 2010 07:33AM


Dec 1, 2009 02:58PM Baird Comments on Onyx Pharmaceuticals (ONXX) On China NDRL Update
Oct 12, 2009 03:28PM Onyx Pharmaceuticals (ONXX) Higher On Proteolix Acquisition, But Not Everyone Convinced
Jul 22, 2009 02:25PM Onyx Pharma (ONXX) calls active on positive Nexavar Phase 2 data
Jul 2, 2009 07:39AM Baird Starts Onyx Pharmaceuticals (ONXX) at Outperform
Feb 19, 2008 09:28AM Pre-Open Movers 2/19: Onyx (ONXX) Lower After Trial Ended, Fossil (FOSL) Higher on Strong Results